| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alternative medicine or unproven methods?
|
|
|
|
12 |
3 |
p. 279
|
artikel
|
| 2 |
A phase I stndy of a fixed dose of cisplatin with increasing doses of raltitrexed (Tomudex®) in the treatment of patients with locally advanced or metastatic squamous cell carcinoma of the head and neck.
|
Huinink, D. Ten Bokkel
|
|
|
12 |
3 |
p. 357-363
|
artikel
|
| 3 |
A phase I study of a fixed dose of cisplatin with increasing doses ofraltitrexed (Tomudex®) in the treatment of patients with locally advancedor metastatic squamous cell carcinoma of the head and neck
|
D. ten Bokkel Huinink
|
|
2001
|
12 |
3 |
p. 357-363
7 p.
|
artikel
|
| 4 |
Awards, appointments
|
|
|
|
12 |
3 |
p. 281
|
artikel
|
| 5 |
Book review
|
Beretta, G.D.
|
|
|
12 |
3 |
p. 284
|
artikel
|
| 6 |
Challenge
|
|
|
|
12 |
3 |
p. 281
|
artikel
|
| 7 |
Changing socioeconomic correlates for cancers of the upper digestive tract
|
Bosetti, C.
|
|
|
12 |
3 |
p. 327-330
|
artikel
|
| 8 |
Changing socioeconomic correlates for cancers of the upper digestivetract
|
C. Bosetti
|
|
2001
|
12 |
3 |
p. 327-330
4 p.
|
artikel
|
| 9 |
CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma?
|
Kim, W.S.
|
|
|
12 |
3 |
p. 349-352
|
artikel
|
| 10 |
CHOP followed by involved field radiation: Is it optimal for localizednasal natural killer/T-cell lymphoma?
|
W. S. Kim
|
|
2001
|
12 |
3 |
p. 349-352
4 p.
|
artikel
|
| 11 |
Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH
|
Weirich, A.
|
|
|
12 |
3 |
p. 311-319
|
artikel
|
| 12 |
Clinical impact of histologic subtypes in localized non-anaplasticnephroblastoma treated according to the trial and study SIOP-9/GPOH
|
A. Weirich
|
|
2001
|
12 |
3 |
p. 311-319
9 p.
|
artikel
|
| 13 |
Contents of the next issue
|
|
|
|
12 |
3 |
p. ix
|
artikel
|
| 14 |
Copyright
|
|
|
|
12 |
3 |
p. vii
|
artikel
|
| 15 |
Deadly and toxic waste? Or intoxication by wastebasket papers?
|
|
|
|
12 |
3 |
p. 280
|
artikel
|
| 16 |
Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice
|
Langer, S.W.
|
|
|
12 |
3 |
p. 405-410
|
artikel
|
| 17 |
Dexrazoxane is a potent and specific inhibitor of anthracycline inducedsubcutaneous lesions in mice
|
S. W. Langer
|
|
2001
|
12 |
3 |
p. 405-410
6 p.
|
artikel
|
| 18 |
Editorial Board
|
|
|
|
12 |
3 |
p. viii
|
artikel
|
| 19 |
Errare humanum est, perseverare diabolicum
|
|
|
|
12 |
3 |
p. 279-280
|
artikel
|
| 20 |
Hearing the bad news of a cancer diagnosis: The Australian melanomapatients perspective
|
P. E. Schofield
|
|
2001
|
12 |
3 |
p. 365-371
7 p.
|
artikel
|
| 21 |
Hearing the bad news of a cancer diagnosis: The Australian melanoma patient’s perspective* * This work was performed at the Sydney Melanoma Unit, Royal Prince Alfred Hospital
|
Schofield, P.E.
|
|
|
12 |
3 |
p. 365-371
|
artikel
|
| 22 |
High-dose progestins for the treatment of cancer anorexia–cachexia syndrome: A systematic review of randomised clinical trials
|
Maltoni, M.
|
|
|
12 |
3 |
p. 289-300
|
artikel
|
| 23 |
High-dose progestins for the treatment of cancer anorexiacachexiasyndrome: A systematic review of randomised clinical trials
|
M. Maltoni
|
|
2001
|
12 |
3 |
p. 289-300
12 p.
|
artikel
|
| 24 |
High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study
|
Peiffert, D.
|
|
|
12 |
3 |
p. 397-404
|
artikel
|
| 25 |
High-dose radiation therapy and neoadjuvant plus concomitant chemotherapywith 5-fluorouracil and cisplatin in patients with locally advancedsquamous-cell anal canal cancer: Final results of a phase II study
|
D. Peiffert
|
|
2001
|
12 |
3 |
p. 397-404
8 p.
|
artikel
|
| 26 |
High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel
|
Crivellari, D.
|
|
|
12 |
3 |
p. 353-356
|
artikel
|
| 27 |
High incidence of central nervous system involvement in patientswith metastatic or locally advanced breast cancer treated withepirubicin and docetaxel
|
D. Crivellari
|
|
2001
|
12 |
3 |
p. 353-356
4 p.
|
artikel
|
| 28 |
Impact of chemotherapy dose-density on radiotherapy dose-intensity afterbreast conserving surgery
|
G. Sanguineti
|
|
2001
|
12 |
3 |
p. 373-378
6 p.
|
artikel
|
| 29 |
Impact of chemotherapy dose-density on radiotherapy dose-intensity after breast conserving surgery* * Presented at the First Meeting of ‘Associazione Italiana di Oncologia Medica’ (AIOM), Rome, October 27, 1999.
|
Sanguineti, G.
|
|
|
12 |
3 |
p. 373-378
|
artikel
|
| 30 |
In this issue
|
|
|
|
12 |
3 |
p. ix
|
artikel
|
| 31 |
Italy, the pain is over
|
|
|
|
12 |
3 |
p. 280
|
artikel
|
| 32 |
Leanness as early marker of cancer of the oral cavity and pharynx
|
Franceschi, S.
|
|
|
12 |
3 |
p. 331-336
|
artikel
|
| 33 |
Leanness as early marker of cancer of the oral cavity and pharynx
|
S. Franceschi
|
|
2001
|
12 |
3 |
p. 331-336
6 p.
|
artikel
|
| 34 |
Matrix metalloproteinase inhibitors: How can we optimize their development?
|
Hidalgo, M.
|
|
|
12 |
3 |
p. 285-287
|
artikel
|
| 35 |
Matrix metalloproteinase inhibitors: How can we optimizetheir development?
|
M. Hidalgo
|
|
2001
|
12 |
3 |
p. 285-287
3 p.
|
artikel
|
| 36 |
Metastatic eccrine porocarcinoma: Response to docetaxel (Taxotere) chemotherapy
|
Plunkett, T.A.
|
|
|
12 |
3 |
p. 411-414
|
artikel
|
| 37 |
Metastatic eccrine porocarcinoma: Response to docetaxel (Taxotere)chemotherapy
|
T. A. Plunkett
|
|
2001
|
12 |
3 |
p. 411-414
4 p.
|
artikel
|
| 38 |
Not all the holes are the same: USDA rules on Emmentaler
|
|
|
|
12 |
3 |
p. 279
|
artikel
|
| 39 |
Not all the holes are the same: USDA rules on Emmentaler;Alternative medicine or unproven methods?; Errare humanum est, perseverarediabolicum; Deadly and toxic waste? Or intoxication by wastebasketpapers?; Italy, the pain is over; US NCI directorship in the new presidentialera; Challenge; Awards, appointments; Perhaps not everyone knows that...
|
|
|
2001
|
12 |
3 |
p. 279-283
5 p.
|
artikel
|
| 40 |
Perhaps not everyone knows that...
|
|
|
|
12 |
3 |
p. 281-283
|
artikel
|
| 41 |
Phase II study of weekly 24-hour intra-arterial high-dose infusion of 5-fluorouracil and folinic acid for liver metastases from colorectal carcinomas
|
Lorenz, M.
|
|
|
12 |
3 |
p. 321-325
|
artikel
|
| 42 |
Phase II study of weekly 24-hour intra-arterial high-dose infusion of5-fluorouracil and folinic acid for liver metastases from colorectalcarcinomas
|
M. Lorenz
|
|
2001
|
12 |
3 |
p. 321-325
5 p.
|
artikel
|
| 43 |
Phase I study of the matrix metalloproteinase inhibitor,BAY 12-9566
|
C. Erlichman
|
|
2001
|
12 |
3 |
p. 389-395
7 p.
|
artikel
|
| 44 |
Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566* * Presented at the 34th American Society of Clinical Oncology annual meeting 1998.
|
Erlichman, C.
|
|
|
12 |
3 |
p. 389-395
|
artikel
|
| 45 |
Reproductive and hormonal factors and ovarian cancer
|
Chiaffarino, F.
|
|
|
12 |
3 |
p. 337-341
|
artikel
|
| 46 |
Reproductive and hormonal factors and ovarian cancer
|
F. Chiaffarino
|
|
2001
|
12 |
3 |
p. 337-341
5 p.
|
artikel
|
| 47 |
Rhinocerebral zygomycosis in a patient with acute lymphoblastic leukemia
|
Lerchenmüller, C.
|
|
|
12 |
3 |
p. 415-419
|
artikel
|
| 48 |
Rhinocerebral zygomycosis in a patient with acute lymphoblasticleukemia
|
C. Lerchenmüller
|
|
2001
|
12 |
3 |
p. 415-419
5 p.
|
artikel
|
| 49 |
Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer
|
Mantz, C.A.
|
|
|
12 |
3 |
p. 343-347
|
artikel
|
| 50 |
Sequential induction chemotherapy and concomitant chemoradiotherapy inthe management of locoregionally advanced laryngeal cancer
|
C. A. Mantz
|
|
2001
|
12 |
3 |
p. 343-347
5 p.
|
artikel
|
| 51 |
Subcutaneous administration of amifostine: A promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy.
|
Penz, M.
|
|
|
12 |
3 |
p. 421-422
|
artikel
|
| 52 |
Subcutaneous administration of amifostine: A promising therapeutic optionin patients with oxaliplatin-related peripheral sensitive neuropathy
|
M. Penz
|
|
2001
|
12 |
3 |
p. 421-422
2 p.
|
artikel
|
| 53 |
Table of Contents
|
|
|
|
12 |
3 |
p. vi-vii
|
artikel
|
| 54 |
The role of hormone replacement therapy in women with a previous diagnosis of breast cancer and a review of possible alternatives
|
Pritchard, K.I.
|
|
|
12 |
3 |
p. 301-310
|
artikel
|
| 55 |
The role of hormone replacement therapy in women with a previousdiagnosis of breast cancer and a review of possible alternatives
|
K. I. Pritchard
|
|
2001
|
12 |
3 |
p. 301-310
10 p.
|
artikel
|
| 56 |
Treatment based on a combination of the CYP2B1/cyclophosphamide system and p53 delivery enhances tumour regression in human pancreatic cancer.
|
Mercadé, E.
|
|
|
12 |
3 |
p. 379-388
|
artikel
|
| 57 |
Treatment based on a combination of the CYP2B1/cyclophosphamidesystem and p53 delivery enhances tumour regression in humanpancreatic cancer
|
E. Mercadé
|
|
2001
|
12 |
3 |
p. 379-388
10 p.
|
artikel
|
| 58 |
Uneventful administration of cisplatin to a man with X-linked Charcot-Marie-Tooth disease (CMT)
|
Cowie, F.
|
|
|
12 |
3 |
p. 422
|
artikel
|
| 59 |
Uneventful administration of cisplatin to a man with X-linkedCharcotMarieTooth disease (CMT)
|
F. Cowie
|
|
2001
|
12 |
3 |
p. 422-422
1 p.
|
artikel
|
| 60 |
US NCI directorship in the new presidential era
|
|
|
|
12 |
3 |
p. 280
|
artikel
|
| 61 |
W. R. Miller & R. J. Santen (eds)., Aromatase Inhibitionand Breast Cancer
|
G. D. Beretta
|
|
2001
|
12 |
3 |
p. 284-284
1 p.
|
artikel
|
Tijdschrift beschrijving